WealthTrak Capital Management’s Moderna MRNA Stock Holding History

WealthTrak Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-70	Closed	-$1.93K	–	599
2025 Q2	$1.93K	Buy	70 +65	+1,300%	+$1.71K	﹤0.01%	446
2025 Q1	$142	Sell	5 -5	-50%	-$177	﹤0.01%	900
2024 Q4	$416	Buy	+10	New	+$478	﹤0.01%	622

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

WealthTrak Capital Management's MRNA Position: Q3 2025 in Review

WealthTrak Capital Management sold out of Moderna (MRNA) in Q3 2025, closing a stake of 70 shares — an estimated $1.93K sold.

WealthTrak Capital Management first reported a position in MRNA in Q4 2024 and held it in 3 quarters. The position peaked at $1.93K in Q2 2025. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

WealthTrak Capital Management reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
WealthTrak Capital Management sold 70 Moderna shares in Q3 2025, an estimated $1.93K.
WealthTrak Capital Management first reported a position in Moderna in Q4 2024 and held it in 3 quarters.
WealthTrak Capital Management's Moderna position peaked at $1.93K in Q2 2025.
643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on WealthTrak Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.